Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Sobi’s partner Biogen Idec to present phase 3 data on prolonged half-life of Haemophilia candidates in young children at annual ASH meeting

[at noodls] – More news 2013-12-03 Press release (PDF) Swedish Orphan Biovitrum AB’s (publ ) (Sobi) partner Biogen Idec today announced that new data from their haemophilia clinical development and research programs … . . . → Read More: Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Sobi’s partner Biogen Idec to present phase 3 data on prolonged half-life of Haemophilia candidates in young children at annual ASH meeting Similar posts: Stock Update: Biogen Idec Inc. (NASDAQ:BIIB) – December 27th Options Now Available For Biogen Idec (BIIB) Surface RT recovery image released to fix Windows RT 8.1 update issues – Microsoft Corporation (NYSE:MSFT) Boeing’s Double Top: Will the company continue to soar?